Picture of Illumina logo

ILMN Illumina Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Momentum

Relative Strength (%)
1m-5.27%
3m+7.53%
6m-4.95%
1yr-31.79%
Volume Change (%)
10d/3m-34.36%
Price vs... (%)
52w High-48.89%
50d MA+1.87%
200d MA-10.3%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)73.51
PEG Ratio (f)6.41
EPS Growth (f)12.95%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value5.11
Price to Tang. Book217.79
Price to Free Cashflow435.58
Price to Sales7.32
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-46.71%
Return on Equity-69.73%
Operating Margin-85.36%

Financial Summary

Year End 2nd JanUnit201820192020202120222023E2024ECAGR / Avg
Total Revenue$m2,398.373,3333,5433,2394,5264,563.355,015.6715.31%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-2.11+82.15+14-30.79+13.85-52.06+25.09n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
2nd Jan 20232nd Jan 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Illumina EPS forecast chart

Profile Summary

Illumina, Inc. is a provider of sequencing- and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Core Illumina products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. GRAIL is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Customers use its platforms to perform whole genome, de novo, exome and ribonucleic acid (RNA) sequencing, and targeted resequencing of specific gene regions and genes. The Company's BeadArray technology produces arrays that can perform many assays simultaneously. Customers use its array-based genotyping consumables for a range of analyses, including diverse species, disease-related mutations, and genetic characteristics associated with cancer.

Directors

Last Annual
January 2nd, 2022
Last Interim
October 2nd, 2022
Incorporated
May 16th, 2000
Public Since
July 28th, 2000
No. of Shareholders
703
No. of Employees
9,800
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
157,300,000

ILMN Share Price Performance

Upcoming Events for ILMN

Q4 2022 Illumina Inc Earnings Release

Q1 2023 Illumina Inc Earnings Release

Illumina Inc Annual Shareholders Meeting

Similar to ILMN

Picture of 10X Genomics logo

10X Genomics

us flag iconNASDAQ Global Select Market

Picture of Abiomed logo

Abiomed

us flag iconNASDAQ Global Select Market

Picture of Accuray logo

Accuray

us flag iconNASDAQ Global Select Market

Picture of Acutus Medical logo

Acutus Medical

us flag iconNASDAQ Global Select Market

Picture of Akoya Biosciences logo

Akoya Biosciences

us flag iconNASDAQ Global Select Market

FAQ

Or unlock with your email

Or unlock with your email